Investigational Drug Information for LB1148
✉ Email this page to a colleague
What is the development status for investigational drug LB1148?
LB1148 is an investigational drug.
There have been 6 clinical trials for LB1148.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 28th 2022.
The most common disease conditions in clinical trials are Tissue Adhesions, Ileus, and COVID-19. The leading clinical trial sponsors are Leading BioSciences, Inc, Ronald Hurst, MD, FACS, and Newsoara Biopharma Co., Ltd.
There are forty-six US patents protecting this investigational drug and zero international patents.
Summary for LB1148
| US Patents | 46 |
| International Patents | 2,000 |
| US Patent Applications | 745 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 5,614 |
| Clinical Trial Progress | Phase 2 (2022-06-28) |
| Vendors | 86 |
Recent Clinical Trials for LB1148
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection | Palisade Bio | Phase 3 |
| LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia | Leading BioSciences, Inc | Phase 2 |
| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection | Leading BioSciences, Inc | Phase 2 |
Clinical Trial Summary for LB1148
Top disease conditions for LB1148
Top clinical trial sponsors for LB1148
US Patents for LB1148
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LB1148 | ⤷ Sign Up | Phosphonate compounds for treatment of medical disorders | Achillion Pharmaceuticals, Inc. (New Haven, CT) | ⤷ Sign Up |
| LB1148 | ⤷ Sign Up | Methods for making ribosomes | Northwestern University (Evanston, IL) | ⤷ Sign Up |
| LB1148 | ⤷ Sign Up | Alkyl cellulose for use in tableting and solid preparation comprising same | Shin-Etsu Chemical Co., Ltd. (Tokyo, JP) | ⤷ Sign Up |
| LB1148 | ⤷ Sign Up | Thickened composition containing lipid peptide-type compound | NISSAN CHEMICAL INDUSTRIES, LTD. (Tokyo, JP) | ⤷ Sign Up |
| LB1148 | ⤷ Sign Up | Dispersion and method for forming hydrogel | NISSAN CHEMICAL INDUSTRIES, LTD. (Tokyo, JP) | ⤷ Sign Up |
| LB1148 | ⤷ Sign Up | External dermal composition for anti-ageing and method for producing the same | HAYASHIBARA CO., LTD. (Okayama, JP) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LB1148
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LB1148 | Taiwan | TW201718611 | 2035-08-26 | ⤷ Sign Up |
| LB1148 | World Intellectual Property Organization (WIPO) | WO2017035357 | 2035-08-26 | ⤷ Sign Up |
| LB1148 | Australia | AU2014296261 | 2033-07-31 | ⤷ Sign Up |
| LB1148 | Brazil | BR112016001600 | 2033-07-31 | ⤷ Sign Up |
| LB1148 | Canada | CA2918242 | 2033-07-31 | ⤷ Sign Up |
| LB1148 | China | CN105814057 | 2033-07-31 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
